- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Services & Solutions
Information Downloads
Protein Sciences
Early-stage R&D Micro Developability Package
|
Micro developability studies consist of a series of advanced assays conducted via high-throughput analysis to evaluate large quantities of different drug candidates. These studies allow lead molecules to be examined at earlier stages of R&D using minimal material. Most of the assays in these studies can be completed within two weeks using less than 1 mg of protein. For small biotech companies, these early-stage micro developability results also allow more accurate assessment and valuation of their assets. |
Micro Developability: Early Assessment of Biologics
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.